LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
WSM
Williams-Sonoma, Inc.
WSM has the edge over LCID overall, supported by lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
WSM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
WSM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
WSM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9x | $87.36 | -65% |
| Fair | 17x | $164 | -34% |
| Expensive | 22x | $212 | -15% |
| Forward | 25x | $250 | — |
| Current | 26x | $250 | — |
Historical ranges are pointers, not guarantees.
WSM's PE is in its expensive range at 26x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
WSM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for WSM, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
WSM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.16 | +4.1% |
| Q3 2026 | $9.76 | +10% |
| Q2 2026 | $8.92 | +3.6% |
| Q1 2026 | $8.84 | +0.6% |
| Q4 2025 | $8.87 | +5% |
| Q3 2025 | $8.87 | +6.7% |
| Q2 2025 | $8.61 | +5.9% |
| Q1 2025 | $8.79 | +21% |
| Q4 2024 | $8.45 | +18% |
WSM has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over WSM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
WSM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +6.7% |
| Q2 2026 | $1.8B | +4.4% |
| Q1 2026 | $2.4B | -4.3% |
| Q4 2025 | $1.9B | +4.6% |
| Q3 2025 | $1.8B | +2.7% |
| Q2 2025 | $1.7B | +4.2% |
| Q1 2025 | $2.5B | +8% |
| Q4 2024 | $1.8B | -2.9% |
WSM's revenue is recovering but still below its 2022 peak: $2B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +5 points |
| Q2 2026 | 16% | -0.6 points |
| Q1 2026 | 20% | +0.1 points |
| Q4 2025 | 17% | -0.9 points |
| Q3 2025 | 18% | +1.6 points |
| Q2 2025 | 17% | -2.7 points |
| Q1 2025 | 20% | 0 points |
| Q4 2024 | 18% | +0.8 points |
WSM has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
WSM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $480.8M | +108% |
| Q2 2026 | $98.6M | +63% |
| Q1 2026 | $516M | -8.9% |
| Q4 2025 | $248.1M | +46% |
| Q3 2025 | $230.7M | +7.3% |
| Q2 2025 | $60.7M | -68% |
| Q1 2025 | $566.3M | -8.8% |
| Q4 2024 | $170.1M | -32% |
WSM has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
WSM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
WSM has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
WSM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.1 | Neutral |
| Stochastic | 66.6 | Neutral |
WSM's weekly RSI is 63 (neutral) and its Stochastic is 67 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
WSM PE vs Consumer Cyclical Sector
| Metric | WSM | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 42% above |
| PE % | 98 | 47 | 51 pts above |
WSM is trading at 26x earnings, a 42% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
WSM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $245.7 | 1.9% above |
| 20 week MA | $237.1 | 5.6% above |
| 50 week MA | $213.1 | 18% above |
| 100 week MA | $197.3 | 27% above |
| 200 week MA | $151.3 | 65% above |
WSM has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
WSM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $53.8 | +47% |
| 2021 | $53.8 | $84.5 | +57% |
| 2022 | $84.5 | $60.1 | -29% |
| 2023 | $60.1 | $100.9 | +68% |
| 2024 | $100.9 | $186.1 | +84% |
| 2025 | $186.1 | $188.6 | +1.4% |
| 2026 YTD | $188.6 | $250.4 | +33% |
WSM has the edge over LCID on returns for 2026, with the stronger performance.